BARCLAYS PLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 87 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$13
+116.7%
105,128
+89.2%
0.00%
Q4 2022$6
-99.4%
55,566
+573.0%
0.00%
Q3 2022$1,000
-88.9%
8,256
-15.5%
0.00%
Q2 2022$9,000
-77.5%
9,774
-69.0%
0.00%
Q1 2022$40,000
-95.6%
31,498
-93.3%
0.00%
Q4 2021$918,000
+321.1%
471,026
+493.3%
0.00%
Q3 2021$218,000
+186.8%
79,396
+228.0%
0.00%
Q2 2021$76,000
+76.7%
24,207
+20.0%
0.00%
Q1 2021$43,00020,1720.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders